Efficacy of BIPAMS for Restless Legs Syndrome in Adults With Multiple
Efficacy of Project BIPAMS for Restless Legs Syndrome in Adults With Multiple Sclerosis: A Pilot Study
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- Behavioral Intervention (BIPAMS)
What it measured
Main measures
Restless Legs Syndrome Severity as measured by the International Restless Legs Syndrome Study Group Scale
Baseline
Restless Legs Syndrome Severity as measured by the International Restless Legs Syndrome Study Group Scale
Follow-Up
Physical Activity Levels as measured by the Godin Leisure-Time Exercise Questionnaire
Baseline
Physical functionPhysical Activity Levels as measured by the Godin Leisure-Time Exercise Questionnaire
Follow-Up
Physical function
Other measures (6)
Sleep Quality as measured by the Pittsburgh Sleep Quality Index
Baseline
Mood and sleepSleep Quality as measured by the Pittsburgh Sleep Quality Index
Follow-up
Mood and sleepSleep Quality as measured by accelerometry
Baseline
Myelin repairMood and sleepSleep Quality as measured by accelerometry
Follow-up
Myelin repairMood and sleepDaytime Sleepiness as measured by the Epworth Sleepiness Scale
Baseline
Walking and mobilityMood and sleepDaytime Sleepiness as measured by the Epworth Sleepiness Scale
Follow-up
Walking and mobilityMood and sleep
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* Diagnosis of multiple sclerosis * Relapse free in the past 30 days * Positive screen for restless legs syndrome * Non-active (not engaging in 30 minutes of activity per day on more than 2 days per week in the previous six months) * Ambulatory without assistance * Internet and email access
Exclusion criteria
* Diagnosis of radiculopathy, peripheral edema, peripheral neuropathy, iron deficiency (i.e., anemia) renal disease, or diabetes * Screen at moderate or high risk for undertaking strenuous or maximal exercise
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The purpose of this study is to evaluate the efficacy of a 16-week behavioral intervention for increasing physical activity and reducing restless legs syndrome (RLS) severity in persons with multiple sclerosis (MS) and RLS. The study includes a proposed sample of 20 persons with MS and RLS that will be randomized into either a 16-week behavioral intervention arm aimed at increasing physical activity or a 16-week wait-list control arm.
Papers
Loading reviews and guidelines…
History
Started
Jan 2020
Main results due
Nov 2020
Finished
Nov 2020